CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Growing demand for antibody-drug conjugates
4.1.2. Increasing demand for oncology drugs
4.1.3. Increasing focus of leading pharmaceutical companies on high potency API(HPAPI)
4.1.4. Advancements in HPAPI manufacturing technologies
4.1.5. Growing focus on precision medicine
4.2. Market Restraints & Challenges
4.2.1. High risk of cross-contamination
4.2.2. Uncertainties associated with products
4.2.3. Differences in HPAPI banding systems
4.2.4. The requirement of large investments
4.2.5. The constant evolution of industry standards and technologies
4.3. Market Opportunities
4.3.1. Emerging markets
4.3.2. Growing opportunities for CMOS and CDMOS
CHAPTER 5 GLOBAL HIGH POTENCY APIs MARKET – BY TYPE
5.1. Innovative high-potency active pharmaceutical ingredients
5.2. Generic high-potency active pharmaceutical ingredients
CHAPTER 6 GLOBAL HIGH POTENCY APIs MARKET – BY TYPE OF
SYNTHESIS
6.1. Synthetic High-Potency Active Pharmaceutical Ingredients
6.1.1. Synthetic High-Potency Active Pharmaceutical Ingredients Market, By
Type.
6.1.1.1. Innovative Synthetic HPAPI
6.1.1.2. Generic Synthetic HPAPI
6.2. Biotech High-Potency Active Pharmaceutical Ingredients
6.2.1. Biotech High-Potency Active Pharmaceutical Ingredients Market, By Type
6.2.1.1. Innovative Biotech HPAPI
6.2.1.2. Biosimilars
6.2.2. Biotech High-Potency Active Pharmaceutical Ingredients Market, By Product
6.3.2.1. Monoclonal Antibodies
6.3.2.2. Vaccines
6.3.2.3. Recombinant Proteins
CHAPTER 7. GLOBAL HIGH POTENCY APIs MARKET – BY MANUFACTURER
TYPE
7.1. Captive HPAPI Manufacturers
7.2 Merchant HPAPI Manufacturers
7.2.1 Merchant HPAPI Manufacturers Market, By Type
7.2.1.1 Innovative Merchant HPAPI Manufacturers
7.2.1.2 Generic Merchant HPAPI Manufacturers
7.2.2 Merchant HPAPI Manufacturers Market, By Type of Synthesis
7.2.2.1 Synthetic HPAPIs
7.2.2.2 Biotech HPAPIs
CHAPTER 8. GLOBAL HIGH POTENCY APIs MARKET – BY THERAPEUTIC
APPLICATION
8.1. Oncology
8.2. Glaucoma
8.3. Hormonal imbalance
8.4. Others
CHAPTER 9. GLOBAL HIGH POTENCY APIs MARKET - BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10. GLOBAL HIGH POTENCY APIs MARKET - COMPANY PROFILES
10.1. Pfizer Inc.
10.2. Novartis International AG
10.3. Sanofi
10.4. F. Hoffmann-La Roche AG
10.5. Bristol-Myers Squibb
10.6. Boehringer Ingelheim GmbH
10.7. Teva Pharmaceutical Industries
10.8. Eli Lilly and Company
10.9. Merck & Co., Ltd
10.10. AbbVie Inc.
10.11. Mylan N.V.
10.12. Bayer AG
10.13. Covidien plc
10.14. Roche Diagnostics AG
10.15. Sigma-Aldrich Corporation
CHAPTER 11. GLOBAL HIGH POTENCY APIs MARKET - COMPETITIVE
LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12. MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13. APPENDIX
13.1. List of Tables
13.2. List of Figures
